A Decade of Nintedanib: An Analysis of the FDA Adverse Event Reporting System Database

被引：0
|
作者：
Niranjan, S. [1 ]
Rao, A. [2 ]
Virk, S. T. [1 ]
Sarangdhar, M. [3 ]
机构：
[1] Allegheny Gen Hosp, Internal Med, Pittsburgh, PA USA
[2] Carnegie Mellon Univ, Quantitat Biol & Bioinformat, Pittsburgh, PA USA
[3] Univ Cincinnati, Biomed Informat, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3746
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
    He, Chang-Zhu
    Qiu, Qin
    Lu, Song-Jie
    Xue, Fu-Li
    Liu, Jun-Qiao
    He, Yu
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [2] Adverse event signal analysis of remimazolam using the FDA adverse event reporting system database
    Liu, Hongtao
    Li, Zhaoyu
    Yan, Su
    Ming, Shaopeng
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2025, 69 (03)
  • [3] A Disproportionality Analysis of Treprostinil Based on FDA Adverse Event Reporting System Database
    Li, Lingling
    Song, Weiqiang
    Jiao, Wanli
    ANNALS OF PHARMACOTHERAPY, 2024,
  • [4] Differences in Anaphylaxis Reporting Among Cephalosporins: Analysis of the FDA Adverse Event Reporting System Database
    Shah, Divya
    Stone, Cosby
    Rukasin, Christine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB77 - AB77
  • [5] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Thomas
    MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110
  • [6] Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database
    Liu, Ruixue
    Liu, Chunxiao
    Feng, Dianwei
    Guo, Tongxin
    Wang, Ying
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
    Rashid Kazerooni
    Edward P. Armstrong
    Clinical Drug Investigation, 2018, 38 : 867 - 872
  • [8] Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
    Kazerooni, Rashid
    Armstrong, Edward P.
    CLINICAL DRUG INVESTIGATION, 2018, 38 (09) : 867 - 872
  • [9] Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database
    Zhao, Shuai
    Wang, Yan
    Deng, Xiaoli
    Chen, Xi
    Lu, Zhaoyi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [10] Botulinum toxin type A overdoses: analysis of the FDA adverse event reporting system database
    Kazerooni, Rashid
    NEUROLOGY, 2019, 92 (15)
12345